Craft

GC Pharma

Stock Price

₩159 K

2024-10-29

Market Capitalization

₩1.8 T

2024-10-29

Revenue

₩2 T

FY, 2025

GC Pharma Summary

Company Summary

Overview
GC Pharma (formerly known as Green Cross Corporation, 녹십자) is a biopharmaceutical company that delivers protein therapeutics and vaccines. It develops and exports a variety of plasma-derived products, including albumin, immunoglobulin, and antithrombin.
Type
Public
Status
Active
Founded
1967
HQ
Yongin-si, KR | view all locations
Website
http://www.globalgreencross.com/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

LocationsView all

1 location detected

  • Yongin-si, Gyeonggi-do HQ

    Korea (Republic of)

    107 Ihyeon-ro 30-beongil, Giheung-gu

GC Pharma Financials

Summary Financials

Revenue (FY, 2025)
₩2.0T
Gross profit (FY, 2025)
₩609.8B
Net income (FY, 2025)
(₩29.7B)
Cash (FY, 2025)
₩49.4B
EBIT (FY, 2025)
₩17.5B
Enterprise value
$2.8T

Footer menu